An interventional study of eCHIS in Malaria, Diarrhea and Pneumonia, sponsored by Malaria Consortium. Recruiting at 1 site in Uganda. Open to participants aged 3 Months to 59 Months. Per ClinicalTrials.gov, last updated 2024-03-19.
Sponsored by Malaria Consortium · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Malaria by Malaria Consortium — 3 open to participants now, 9 under way, 2 of them phase 3. Malaria · Malaria Consortium.
Among the 10 studies in Malaria by Malaria Consortium, this one is one of 4 that started in 2023, is one of 3 with no phase, and was the 9th registered.
1,186 studies on the registry are indexed under Malaria; 80 are open to participants now.
Browse Malaria studies →3 of the 10 studies in Malaria by Malaria Consortium are open now, in 3 countries. Recruiting first, the newest first:
Malaria Consortium · Sites in Nigeria
Ages 3 mo–59 mo · Healthy volunteers
Malaria Consortium · Sites in Burkina Faso
Ages 5–15
By country, each count listing its studies:
Of the 51 Malaria studies recruiting now, 15 (29%) set no upper age limit and 33 (65%) stop at 75 or younger; 37 take children under 18; 31 take healthy volunteers.
This study: 3 Months to 59 Months · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 4 started in 2023.
This study's planned enrollment of 1,140 is above the median of 252 across 939 interventional studies indexed under Malaria.
Median enrollment 2,289 across the 9 interventional studies, 300 across the 1 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Malaria Consortium is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Malaria by Malaria Consortium, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to investigate the impact of the eCHIS intervention on key child health outcomes.
Following national guidelines, 2 VHTs per village will be supported to provide the full eCHIS community health package. In total 856 VHTs in Buikwe district will have been trained and equipped with the national strategy and operational guidelines on eCHIS as well as the VHT full package (iCCM+ and VHT basic package (reproductive health, immunization, nutrition) guidelines. The VHTs will be equipped with mobile devices and iCCM supplies to start the management of community-based health among children aged five years within their respective communities. A cross-sectional cluster randomized controlled trial (cRCT) will be used to establish study outcomes in children under 5 years in the intervention and control areas using mixed methods (qualitative and quantitative) of data collection.
A total sample size of 1,140 children under five: 570 children under five, per arm, was scientifically determined for the study. During data collection, several quality control measures will be applied to ensure the data recorded reflect the facts, responses, observations, and events. A standard operating procedure (SOP) with roles and responsibilities of the data collectors will be prepared to ensure standardized methods for capturing data. After endline data collection, difference-in-differences (DID) analysis will be done to derive an estimate of the intervention effect on odds of the study outcomes.
Results will be disseminated through agreed peer-review publications and international conferences. Malaria Consortium Uganda will work with relevant stakeholders at the Ministry of Health and Medic Mobile to disseminate findings nationally and throughout the study district.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children between 3-59 months,
Exclusion Criteria:
570 children will be allocated to the intervention arm and children in this arm will be assessed using the eCHIS digital tool.
Other: eCHIS
570 children will be allocated to the intervention arm and children in this arm will be assessed using the standard care and paper based tools.
The electronic Community health Information System (eCHIS) is a Government of Uganda owned application used by community health workers for quality health assessments and improved reporting. The eCHIS intervention allows for the registration of longitudinal profiles for client centered care as well as provides care guidance to aid decision making. For its users, the app has a task tab for schedule management and dashboards for performance help management and impact tracking by supervisors. This app is interoperable with national reporting tools such as DHIS2. The app has ten workflows including registration of households and new persons, death reporting, iCCM assessment, treatment and referral follow up, stock monitoring, data synchronization, pregnancy registration, ANC danger signs and follow up, family planning registration, and screening (tuberculosis, hypertension, sickle cell, tobacco use and net use).
Out Patient Department attendance (due to malaria, pneumonia and diarrhoea)
Attendance measured through baseline and endline surveys
Time frame: Over 1 year
Hospitalisation (due to malaria, pneumonia and diarrhoea)
Attendance measured through baseline and endline surveys
Time frame: Over 1 year
malaria related mortality in the community and health facilities
Malaria related mortality measured through routine data
Time frame: Over 1 year
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Apr 2024, 4 months after the start.
Of 96 non-industry interventional studies with no phase under Malaria, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 4 months is below that.
Counting every sponsor, half of 102 studies reached it within 23 months; a quarter within 8 and three quarters within 33.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Malaria Consortium